Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pamabrom |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amisometradine |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Sulfonamide diuretic |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Aminometradine |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Chlorazanil |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Saluretic agent (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Loop diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Thiazide diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Potassium-sparing diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Uricosuric agent (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Osmotic diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Carbonic anhydrase inhibitor |
Is a |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Quinazoline diuretic |
Is a |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Mercurial diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
Poisoning caused by diuretic |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
Diuretic identification (procedure) |
Component |
True |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Medicinal product acting as saluretic (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Purine diuretic poisoning |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
2 |
Theobromine poisoning |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Purine diuretic poisoning NOS |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Other diuretic poisoning |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Other diuretic poisoning NOS |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Harmful pattern of use of diuretic (disorder) |
Causative agent (attribute) |
True |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
Thiazide diuretic poisoning |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Diuretic adverse reaction |
Causative agent (attribute) |
True |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
Potassium sparing compound diuretic adverse reaction |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride and loop diuretic adverse reaction |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride and thiazide diuretic adverse reaction |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Spironolactone and loop diuretic adverse reaction |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Spironolactone and thiazide diuretic adverse reaction |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Triamterene and loop diuretic adverse reaction |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Triamterene and thiazide diuretic adverse reaction |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Allergy to diuretic |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Potassium sparing compound diuretic allergy |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride and loop diuretic allergy |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Allergy to amiloride and thiazide diuretic |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Allergy to spironolactone and loop diuretic |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Allergy to spironolactone and thiazide diuretic |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Triamterene and loop diuretic allergy |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Allergy to triamterene and thiazide diuretic |
Causative agent (attribute) |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Diuretic overdose |
Causative agent (attribute) |
True |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
médicament diurétique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Potassium sparing compound diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Co-triamterzide 50mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Furosemide 20 mg and spironolactone 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Co-amilofruse tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Co-amilozide 5mg/50mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Hydroflumethiazide 25 mg and spironolactone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Diuretics with potassium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Bumetanide+potassium 500mcg/7.7Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Frusemide+potassium 40mg/8Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Frusemide+potassium 20mg/10Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Bendrofluazide+potassium 2.5mg/8.4Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing precisely clopamide 5 milligram and pindolol 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Co-prenozide tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride+loop diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Amiloride+thiazide diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Nadolol+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Oxprenolol+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Pindolol+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Propranolol+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Sotalol hydrochloride+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Spironolactone+loop diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Spironolactone+thiazide diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Timolol maleate+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Triamterene+loop diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Triamterene+thiazide diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Co-triamterzide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Co-amilozide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing hydroflumethiazide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Co-amilofruse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Product containing cyclopenthiazide and oxprenolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Angiotensin II receptor antagonist+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Purine diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Quinazoline diuretic product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Uricosuric product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Hydrochlorothiazide + timolol maleate 25mg/10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Bendrofluazide - chemical |
Is a |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|